We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,031 hedge funds and large institutions have $164B invested in Thermo Fisher Scientific in 2020 Q4 according to their latest regulatory filings, with 276 funds opening new positions, 751 increasing their positions, 739 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed

294% more first-time investments, than exits

New positions opened: 276 | Existing positions closed: 70

10% more funds holding

Funds holding: 1,8472,031 (+184)

5% more capital invested

Capital invested by funds: $156B → $164B (+$8.53B)

2% more repeat investments, than reductions

Existing positions increased: 751 | Existing positions reduced: 739

0.99% less ownership

Funds ownership: 89.16%88.17% (-0.99%)

7% less funds holding in top 10

Funds holding in top 10: 198184 (-14)

19% less call options, than puts

Call options by funds: $976M | Put options by funds: $1.21B

Holders
2,031
Holders Change
+184
Holders Change %
+9.96%
% of All Funds
35.93%
Holding in Top 10
184
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-7.07%
% of All Funds
3.26%
New
276
Increased
751
Reduced
739
Closed
70
Calls
$976M
Puts
$1.21B
Net Calls
-$229M
Net Calls Change
-$95M
Name Holding Trade Value Shares
Change
Change in
Stake
ET
826
Equitable Trust
Tennessee
$4.03M +$1.41K +3 +0%
TC
827
TownSquare Capital
Utah
$4.02M -$53K -113 -1%
PBT
828
Pictet Bank & Trust
Bahamas
$4.01M -$2.07M -4,405 -34%
LIM
829
Leavell Investment Management
Alabama
$4.01M +$203K +433 +5%
EB
830
Eastern Bank
Massachusetts
$3.99M -$15.5K -33 -0.4%
CI
831
Conning Inc
Connecticut
$3.98M -$77.4K -165 -2%
AAMU
832
AEGON Asset Management (UK)
United Kingdom
$3.97M
VRM
833
Vectors Research Management
New York
$3.97M +$65.6K +140 +2%
CNC
834
Canandaigua National Corp
New York
$3.97M +$482K +1,027 +14%
HC
835
HNP Capital
New York
$3.96M +$61.9K +132 +2%
CG
836
Colony Group
Massachusetts
$3.94M -$506K -1,079 -11%
MCA
837
Morris Capital Advisors
Pennsylvania
$3.93M -$230K -491 -5%
HPWM
838
High Pines Wealth Management
Massachusetts
$3.91M +$3.94M +8,398 New
PCA
839
Providence Capital Advisors
North Carolina
$3.89M +$280K +597 +8%
MJRIC
840
Mogy Joel R Investment Counsel
California
$3.88M +$392K +837 +11%
BHIA
841
Birch Hill Investment Advisors
Massachusetts
$3.87M +$290K +618 +8%
WAM
842
World Asset Management
Michigan
$3.85M -$27.2K -58 -0.7%
LSA
843
Leonteq Securities AG
Switzerland
$3.85M +$3.87M +8,261 New
BIM
844
Baldwin Investment Management
Pennsylvania
$3.81M +$155K +330 +4%
OSNBOA
845
Old Second National Bank of Aurora
Illinois
$3.77M -$113K -241 -3%
CAM
846
Cresset Asset Management
Illinois
$3.77M +$255K +544 +7%
OSAM
847
O'Shaughnessy Asset Management
Connecticut
$3.76M +$1.88M +4,014 +99%
SSI
848
Scott & Selber Inc
Texas
$3.76M -$174K -372 -4%
PAMG
849
Patton Albertson Miller Group
Tennessee
$3.75M -$20.2K -43 -0.6%
ERWM
850
Elk River Wealth Management
Colorado
$3.71M +$3.73M +7,961 New

TMO Hedge Fund Activity: Q4 2020 in Review

2,031 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2020, worth a combined $164B — up 5.5% from $156B a quarter earlier.

Buyers outnumbered sellers: 276 funds opened new TMO positions and 70 closed out — a net gain of 206 holders — while 751 added to existing stakes and 739 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $322M. The largest seller was Capital Research Global Investors, cutting an estimated $770M.

  • 2,031 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2020, up from 1,847 in Q3 2020.
  • Funds reported $164B of Thermo Fisher Scientific stock for Q4 2020, up 5.5% quarter-over-quarter.
  • 276 funds opened new Thermo Fisher Scientific positions in Q4 2020 and 70 closed out, a net change of +206 holders.
  • The largest Thermo Fisher Scientific buyer in Q4 2020 was Fidelity Investments, an estimated $322M added.
  • The largest Thermo Fisher Scientific seller in Q4 2020 was Capital Research Global Investors, an estimated $770M sold.

Based on aggregated 13F filings for Q4 2020.